Microwave-Assisted Synthesis of (E)-α-Methylalkenoate Framework from Multifunctionalized Allylic Phosphonium Salts 183
[(Z)-2-Methoxycarbonyl-3-(3,4-methylenedioxyph
[(Z)-3-(2-Chlorophenyl)-2-methoxycarbonyl-2-
propenyl]triphenylphosphonium Bromide (1f).
enyl)-2-propenyl]triphenylphosphonium
Bromide
(1c). White solid; mp: 192.0–194.0◦C; IR (KBr):
νmax 3443, 3404, 3057, 2899, 1700, 1610, 1491, 1436,
White solid; mp: 127.0–128.5◦C; IR (KBr): νmax 3418,
3375, 3004, 2950, 2889, 1716, 1634, 1587, 1437, 1265,
1111 cm−1; 1H NMR (CDCl3): δ 3.32 (s, 3H), 5.00 (d,
J = 15.2 Hz, 2H), 7.07 (d, J = 7.8 Hz, 1H), 7.25 (t,
J = 7.8 Hz, 1H), 7.47–7.60 (m, 13H), 7.67–7.71 (m,
3H), 7.88 (d, J = 7.4 Hz, 1H), 7.98 (d, J = 5.5 Hz,
1H); 13C NMR (CDCl3): δ 24.1 (d, J = 50.0 Hz, CH2),
52.9 (CH3), 117.7 (d, J = 85.7 Hz, 3 × CP), 122.8
(d, J = 9.6 Hz, C), 128.9 (CH), 130.0 (CH), 130.4
(d, J = 12.4 Hz, 6× CPH), 131.0 (CH), 131.3 (CH),
132.6 (C), 133.4 (C), 134.1 (d, J = 10.2 Hz, 6 × CPH),
135.2 (3 × CPH), 144.2 (d, J = 9.6 Hz, CH), 166.0 (C);
31P NMR (CDCl3, 85% H3PO4 as external standard):
δ 21.7; Anal. Calcd for C29H25BrClO2P (%): C, 63.12;
H, 4.57. Found: C, 62.90; H, 4.70.
1
1234, 1113 cm−1; H NMR (CDCl3): δ 3.38 (s, 3H),
5.07 (d, J = 14.8 Hz, 2H), 5.97 (s, 2H), 6.62 (s, 1H),
6.80 (d, J = 8.0 Hz, 1H), 7.03 (d, J = 8.0 Hz, 1H),
7.60–7.71 (m, 12H), 7.75–7.79 (m, 3H), 7.82 (d, J =
4.7 Hz, 1H); 13C NMR (CDCl3): δ 25.3 (d, J = 50.3
Hz, CH2), 52.8 (CH3), 101.9 (CH2), 108.6 (CH), 109.5
(CH), 118.1 (d, J = 84.6 Hz, 3 × CP), 119.5 (d, J =
10.0 Hz, C), 124.3 (CH), 127.4 (C), 130.4 (d, J =
12.2 Hz, 6 × CPH), 134.2 (d, J = 9.2 Hz, 6 × CPH),
135.3 (3 × CPH), 146.3 (d, J = 9.9 Hz, CH), 148.5
(C), 149.3 (C), 166.9 (C); 31P NMR (CDCl3, 85%
H3PO4 as external standard): δ 22.1; Anal. Calcd for
C30H26BrO4P (%): C, 64.18; H, 4.67. Found: C, 64.37;
H, 5.05.
[(Z)-3-(2,4-Dichlorophenyl)-2-methoxycarbonyl-
2-propenyl]triphenylphosphonium Bromide (1g).
White solid; mp: 178.0–180.0◦C; IR (KBr): νmax 3415,
3059, 3006, 2949, 1715, 1641, 1586, 1438, 1289,
[(Z)-2-Methoxycarbonyl-3-(4-methylphenyl) -2-
propenyl]triphenylphosphonium
Bromide
(1d).
White solid, mp 180.0–181.0◦C; IR (KBr): νmax 3450,
3396, 3056, 3006, 2951, 2897, 1710, 1631, 1586,
1
1255, 1109 cm−1; H NMR (CDCl3): δ 3.36 (s, 3H),
1
1436, 1263, 1110 cm−1; H NMR (CDCl3): δ 2.34 (s,
5.28 (d, J = 15.6 Hz, 2H), 7.01 (d, J = 2.0 Hz, 1H),
7.52–7.57 (m, 6H), 7.62–7.73 (m, 10H), 7.97 (d, J =
5.6 Hz, 1H), 8.25 (d, 8.2 Hz, 1H); 13C NMR (CDCl3):
δ 24.1 (d, J = 49.5 Hz, CH2), 52.9 (CH3), 117.6 (d,
J = 84.6 Hz, 3 × CP), 123.3 (d, J = 10.0 Hz, C), 129.3
(CH), 129.4 (CH), 130.3 (d, J = 13.0 Hz, 6 × CPH),
131.0 (C), 132.8 (CH), 133.8 (C), 134.0 (d, J = 10.0
Hz, 6 × CPH), 135.0 (3 × CPH), 136.1 (C), 142.9 (d,
J = 10.0 Hz, CH), 165.7 (C); 31P NMR (CDCl3, 85%
H3PO4 as external standard): δ 21.4; Anal. Calcd for
C29H24Cl2BrO2P (%): C, 59.41; H, 4.14. Found: C,
59.10, H, 4.43.
3H), 3.39 (s, 3H), 5.10 (d, J = 14.8 Hz, 2H), 7.13 (d,
J = 8.0 Hz, 2H), 7.23 (d, J = 8.0, 2H), 7.57–7.70 (m,
12H), 7.72–7.77 (m, 3H), 7.92 (d, J = 4.9 Hz, 1H);
13C NMR (CDCl3): δ 21.1 (CH3), 24.5 (d, J = 49.3 Hz,
CH2), 52.3 (CH3), 117.5 (d, J = 84.9 Hz, 3× CP), 119.8
(d, J = 9.1 Hz, C), 128.4 (2 × CH), 129.7 (2 × CH),
129.9 (d, J = 11.4 Hz, 6 × CPH), 133.6 (6 × CPH),
134.0 (C), 134.8 (3 × CPH), 139.9 (C), 146.2 (d,
J = 8.3 Hz, CH), 166.3 (C); 31P NMR (CDCl3, 85%
H3PO4 as external standard): δ 22.6; Anal. Calcd for
C30H28BrO2P (%): C, 67.80; H, 5.31. Found: C, 67.90;
H, 5.50.
[(Z)-3-(4-Chlorophenyl)-2-methoxycarbonyl-2-
[(Z)-3-(4-Bromophenyl)-2-methoxycarbonyl-2-
propenyl]triphenylphosphonium
Bromide
(1e).
propenyl]triphenylphosphonium
Bromide
(1h).
White solid; mp: 169.5–171.5◦C; IR (KBr): νmax 3435,
White solid; mp: 118.0–120.0◦C; IR (KBr): νmax 3489,
3408, 3048, 3003, 2948, 1701, 1623, 1588, 1436,
3428, 3054, 3006, 2952, 1713, 1634, 1584, 1437,
1
1
1293, 1110 cm−1; H NMR (CDCl3): δ 3.38 (s, 3H),
1264, 1111 cm−1; H NMR (CDCl3): δ 3.36 (s, 3H),
5.22 (d, J = 15.2 Hz, 2H), 7.31 (d, J = 8.2 Hz,
2H), 7.43 (d, J = 8.2 Hz, 2H), 7.55–7.60 (m, 6H),
7.64–7.75 (m, 9H), 7.90 (d, J = 4.8 Hz, 1H); 13C NMR
(CDCl3): δ 24.3 (d, J = 49.8 Hz, CH2), 52.6 (CH3),
117.5 (d, J = 85.0 Hz, 3 × CP), 121.4 (d, J = 9.6 Hz,
C), 129.4 (2 × CH), 130.0 (d, J = 12.5 Hz, 6 × CPH),
130.1 (2 × CH), 131.8 (C), 133.8 (d, J = 9.6 Hz,
6 × CPH), 134.9 (3 × CPH), 135.5 (C), 144.9 (d,
J = 8.8 Hz, CH), 166.1 (C); 31P NMR (CDCl3, 85%
H3PO4 as external standard): δ 22.2; Anal. Calcd for
C29H25BrClO2P (%): C, 63.12; H, 4.57. Found: C,
63.10; H, 4.60.
5.09 (d, J = 15.0 Hz, 2H), 7.31 (d, J = 8.6 Hz,
2H), 7.43 (d, J = 8.6 Hz, 2H), 7.54–7.64 (m, 12H),
7.70–7.75 (m, 3H), 7.86 (d, J = 5.5 Hz, 1H); 13C
NMR (CDCl3): δ 24.6 (d, J = 48.8 Hz, CH2), 52.9
(CH3), 118.0 (d, J = 84.5 Hz, 3 × CP), 121.8 (d, J =
10.0 Hz, C), 124.2 (C), 130.3 (d, J = 12.2 Hz, 6 ×
CPH), 130.6 (2 × CH), 132.5 (C), 132.7 (2 × CH),
134.2 (d, J = 10.0 Hz, 6 × CPH), 135.2 (3 × CPH),
145.4 (d, J = 10.7 Hz, CH), 166.5 (C); 31P NMR
(CDCl3, 85% H3PO4 as external standard): δ 22.3;
Anal. Calcd for C29H25Br2O2P (%): C, 58.41; H, 4.23.
Found: C, 58.10; H, 4.40.
Heteroatom Chemistry DOI 10.1002/hc